Back to News & Events

Participant Feasibility: Direct Engagement With Patients to Impact MASH Trial Design and Site Selection

Share this

The scientific poster titled “Participant Feasibility: Direct Engagement with Patients to Impact MASH Trial Design and Site Selection” evaluates data from ProSciento’s PRO PASS® platform, presented at this year’s NASH Paris Meeting.  The poster evaluates the data from pre-study participant feasibility campaigns for 12 metabolic dysfunction-associated steatohepatitis (MASH) study protocols utilizing a database of 29,879 individuals with comorbidities related to the prevalence of MASH/MASLD. The resulting insights held significant value in demonstrating study feasibility, identifying participation barriers, aiding in site selection decisions, enhancing patient enrollment and retention, and ultimately improving overall efficiency.

NASH Paris

Your development journey
starts with a conversation.

ProSciento
Privacy Overview

More information about our Privacy Policy can be found here.